Dengue Therapeutic Pipeline Drugs and Companies Review H1 2015 Report at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Dengue – Pipeline Review, H1 2015” to its store. The report provides an overview of the Dengue’s therapeutic pipeline.

Dengue Therapeutic Pipeline Drugs and Companies Review

Dengue Therapeutic Pipeline Drugs and Companies Review

The report "Dengue – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Dengue. Dengue is a disease caused by bite of the mosquito (Aedes Mosquito) which is infected with a dengue virus. The disease can affect a person through fever, headache, muscle and joint pain. The disease if not cured on time may result into fatal occurrences like dengue hemorrhagic fever. The disease may also result in failure of the circulatory systems of the body. Dengue is found in the Asian Subcontinent. These are primarily the regions wherein the population is crowded & there is scope for the mosquitoes to quantify. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Complete Report is Available @ http://www.rnrmarketresearch.com/dengue-pipeline-review-h1-2015-market-report.html .

It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects. Companies discussed in this Dengue Pipeline Review H1 2015 report include Agilvax, Inc., AltraVax Inc., Arbovax, Inc., BioDiem Ltd, Biotron Limited, Cocrystal Pharma, Inc., Codagenix, Inc., FIT Biotech Oyj, GlaxoSmithKline plc, Humabs BioMed SA, Immunovaccine, Inc., Johnson & Johnson, Kineta, Inc., MacroGenics, Inc., Medivir AB, Merck & Co., Inc., Molplex Ltd., Myelo Therapeutics GmbH, NanoViricides, Inc., Panacea Biotec Limited, PaxVax, Prosetta Antiviral Inc., RFS Pharma, LLC, Sanofi Pasteur SA, Sarepta Therapeutics, Inc., SIGA Technologies, Inc., SKAU Vaccines ApS, Takeda Pharmaceutical Company Limited, TechnoVax, Inc., Themis Bioscience GmbH, United Therapeutics Corporation, VaxInnate Corporation, Visterra, Inc.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269512 . (This is a premium report priced at US$2000 for a single user License.)

Table of Contents

List of Tables
Number of Products under Development for Dengue, H1 2015
Number of Products under Development for Dengue - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Dengue - Pipeline by Agilvax, Inc., H1 2015
Dengue - Pipeline by AltraVax Inc., H1 2015
Dengue - Pipeline by Arbovax, Inc., H1 2015
Dengue - Pipeline by BioDiem Ltd, H1 2015
Dengue - Pipeline by Biotron Limited, H1 2015
Dengue - Pipeline by Cocrystal Pharma, Inc., H1 2015
Dengue - Pipeline by Codagenix, Inc., H1 2015
Dengue - Pipeline by FIT Biotech Oyj, H1 2015
Dengue - Pipeline by GlaxoSmithKline plc, H1 2015
Dengue - Pipeline by Humabs BioMed SA, H1 2015
Dengue - Pipeline by Immunovaccine, Inc., H1 2015
Dengue - Pipeline by Johnson & Johnson, H1 2015
Dengue - Pipeline by Kineta, Inc., H1 2015
Dengue - Pipeline by MacroGenics, Inc., H1 2015
Dengue - Pipeline by Medivir AB, H1 2015
Dengue - Pipeline by Merck & Co., Inc., H1 2015
Dengue - Pipeline by Molplex Ltd., H1 2015
Dengue - Pipeline by Myelo Therapeutics GmbH, H1 2015
Dengue - Pipeline by NanoViricides, Inc., H1 2015
Dengue - Pipeline by Panacea Biotec Limited, H1 2015
Dengue - Pipeline by PaxVax, H1 2015
Dengue - Pipeline by Prosetta Antiviral Inc., H1 2015
Dengue - Pipeline by RFS Pharma, LLC, H1 2015
Dengue - Pipeline by Sanofi Pasteur SA, H1 2015
Dengue - Pipeline by Sarepta Therapeutics, Inc., H1 2015
Dengue - Pipeline by SIGA Technologies, Inc., H1 2015
Dengue - Pipeline by SKAU Vaccines ApS, H1 2015

Explore more reports on Infectious Diseases Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@LifeSciReports
Follow >
Sandler Research
since: 04/2014
Like >
Follow us on
Visit website